Clinician's perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19.

Yildiz, Murat; Aksu, Funda; Yildiz, Nurdan; Aksu, Kurtulus

Yildiz, Murat; Aksu, Funda; Yildiz, Nurdan; Aksu, Kurtulus.

Afiliação

Yildiz M; University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Department of Chest Diseases - Ankara, Turkey.
Aksu F; University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Department of Chest Diseases - Ankara, Turkey.
Yildiz N; University of Health Sciences, Ankara City Hospital, Department of Family Medicine - Ankara, Turkey.
Aksu K; University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Department of Chest Diseases, Division of Immunology and Allergy - Ankara, Turkey.

Rev Assoc Med Bras (1992) ; 67Suppl 1(Suppl 1): 97-101, 2021.

Article em En | MEDLINE | ID: mdl-34406300

Assuntos

COVID-19; Doença Pulmonar Obstrutiva Crônica; Adulto; Feminino; Humanos; Masculino; Adesão à Medicação; Pessoa de Meia-Idade; Pandemias; Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / COVID-19 Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google